Talzenna
NDC 63539-031, talazoparib, capsule, liquid filled, from U.S. Pharmaceuticals.
- Product NDC
- 63539-031
- Status
- Listed
- Labeler
- U.S. Pharmaceuticals
- Dosage form
- CAPSULE, LIQUID FILLED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA217439
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63539-031 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TALAZOPARIB TOSYLATE1 mg/1
Pharmacologic classes
Poly(ADP-Ribose) Polymerase Inhibitor [EPC]; Poly(ADP-Ribose) Polymerase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63539-031-30 | 63539003130 | 30 CAPSULE, LIQUID FILLED in 1 BOTTLE (63539-031-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b653221e-971f-4452-92d4-797924f1ff59
Use it
Look up 63539-031 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63539-031 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63539-031. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.